Stay current with the latest press releases from within the industry.
Release issued 22nd March 2004BIO BALANCE and DSS INFOTECH INTERNATIONAL complete development of a prototype program that calculates the high and low affinities of BIO BALANCE'S two-state, biophysical model for the initial receptor response. "This will allow researchers to enter their raw dose-response data and obtain a complete set of fitted parameters to our biophysical model." said Richard Lanzara, President of BIO BALANCE. This should encourage the research community to use this model to fit their dose-response curves and obtain meaningful biophysical parameters for their investigational drugs.
If you want to find out more about the company visit Bio Balance, Inc. profile.
(8th July 2004) The Overlooked Problem of Drug-Receptor Desensitization
(23rd June 2004) New Research Friendly Links From BIO BALANCE
(2nd March 2004) BIO BALANCE announces the opening of a new bioinformatics site
(26th February 2004) BIO BALANCE Announces An Open Scientific Policy
(5th January 2004) Bio Balance has upgraded its website.
Clients in focus...